McEwen Mining Valuation
Is US8 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of US8 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate US8's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate US8's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for US8?
Other financial metrics that can be useful for relative valuation.
What is US8's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$605.75m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.7x |
Enterprise Value/EBITDA | -8.7x |
PEG Ratio | -0.07x |
Price to Earnings Ratio vs Peers
How does US8's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 8.5x | ||
02P Pearl Gold | 2.5x | n/a | €8.5m |
SZG Salzgitter | 6.7x | 10.3% | €1.3b |
ACT AlzChem Group | 13.3x | 12.6% | €461.0m |
STO3 Sto SE KGaA | 11.5x | 4.4% | €1.0b |
US8 McEwen Mining | 10.9x | -146.9% | €605.8m |
Price-To-Earnings vs Peers: US8 is expensive based on its Price-To-Earnings Ratio (10.9x) compared to the peer average (8.5x).
Price to Earnings Ratio vs Industry
How does US8's PE Ratio compare vs other companies in the European Metals and Mining Industry?
Price-To-Earnings vs Industry: US8 is good value based on its Price-To-Earnings Ratio (10.9x) compared to the European Metals and Mining industry average (13.5x).
Price to Earnings Ratio vs Fair Ratio
What is US8's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 10.9x |
Fair PE Ratio | 0.5x |
Price-To-Earnings vs Fair Ratio: US8 is expensive based on its Price-To-Earnings Ratio (10.9x) compared to the estimated Fair Price-To-Earnings Ratio (0.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | €11.40 | €10.82 -5.1% | 11.1% | €11.97 | €9.21 | n/a | 4 |
Apr ’25 | €9.05 | €10.82 +19.6% | 11.1% | €11.97 | €9.21 | n/a | 4 |
Mar ’25 | €5.95 | €12.11 +103.6% | 25.0% | €17.07 | €9.23 | n/a | 4 |
Feb ’25 | €5.90 | €12.69 +115.1% | 21.7% | €17.31 | €10.29 | n/a | 4 |
Jan ’25 | €6.60 | €12.69 +92.3% | 21.7% | €17.31 | €10.29 | n/a | 4 |
Dec ’24 | €7.00 | €12.69 +81.3% | 21.7% | €17.31 | €10.29 | n/a | 4 |
Nov ’24 | €6.55 | €13.54 +106.8% | 25.2% | €19.40 | €11.12 | n/a | 4 |
Oct ’24 | €6.30 | €12.05 +91.2% | 25.7% | €17.36 | €9.82 | n/a | 4 |
Sep ’24 | €7.45 | €12.05 +61.7% | 25.7% | €17.36 | €9.82 | n/a | 4 |
Aug ’24 | €7.85 | €11.89 +51.5% | 24.3% | €16.84 | €9.79 | n/a | 4 |
Jul ’24 | €6.50 | €11.89 +82.9% | 24.3% | €16.84 | €9.79 | n/a | 4 |
Jun ’24 | €7.15 | €11.78 +64.8% | 24.9% | €16.85 | €9.79 | n/a | 4 |
May ’24 | €7.40 | €9.69 +30.9% | 5.9% | €10.09 | €8.71 | n/a | 4 |
Apr ’24 | €8.00 | €9.95 +24.4% | 5.9% | €10.36 | €8.95 | €9.05 | 4 |
Mar ’24 | €6.40 | €9.60 +50.1% | 5.3% | €10.37 | €8.96 | €5.95 | 4 |
Feb ’24 | €6.15 | €9.50 +54.5% | 3.5% | €9.98 | €9.03 | €5.90 | 4 |
Jan ’24 | €5.45 | €9.44 +73.1% | 3.5% | €9.91 | €8.96 | €6.60 | 4 |
Dec ’23 | €5.20 | €9.68 +86.1% | 5.7% | €10.42 | €8.93 | €7.00 | 4 |
Nov ’23 | €3.68 | €10.53 +186.2% | 17.6% | €13.64 | €8.77 | €6.55 | 4 |
Oct ’23 | €3.18 | €10.53 +231.2% | 17.6% | €13.64 | €8.77 | €6.30 | 4 |
Sep ’23 | €3.04 | €10.53 +246.0% | 17.6% | €13.64 | €8.77 | €7.45 | 4 |
Aug ’23 | €3.85 | €13.46 +249.9% | 21.0% | €17.29 | €9.88 | €7.85 | 4 |
Jul ’23 | €4.02 | €13.18 +227.8% | 20.3% | €16.77 | €9.59 | €6.50 | 4 |
Jun ’23 | €5.48 | €13.18 +140.4% | 20.3% | €16.77 | €9.59 | €7.15 | 4 |
May ’23 | €6.51 | €14.58 +124.0% | 7.1% | €15.82 | €13.56 | €7.40 | 4 |
Apr ’23 | €7.46 | €14.58 +95.4% | 7.1% | €15.82 | €13.56 | €8.00 | 4 |
Analyst Forecast: Target price is lower than the current share price.